• Skip to primary navigation
  • Skip to main content
ASC Therapeutics

ASC Therapeutics

Genes and Cells for Cure

  • About Us
    • Our Team
    • Hemophilia Advisory Board
    • Cell Therapy Advisory Board
  • Our Technology
  • Focus
    • Gene Therapy
    • Stem Cell Therapy
  • Our Pipeline
  • Our Partners
  • Investors
    • Investors
    • Releases
  • News
    • Publications
    • Industry News
    • Company News

Company News

Watch the HDD talk describing our 2nd Generation Gene Therapy for Hemophilia A

Read More

Presentation of Preclinical Development Results of ASC-618

Read More

Clinical Development of Advanced Gene Therapies for Hemophilia.

https://www.youtube.com/watch?v=yicEn7XZ-W8&feature=youtu.be

Read More

ASC Therapeutics and Vigene Announce Long-Term Strategic Partnership for Gene Therapy Development and Manufacturing

MILPITAS, Calif.–(BUSINESS WIRE)–ASC Therapeutics (“ASC”), a privately-held gene therapy company...

Read More

ASC Therapeutics Licenses Tech from Expression Therapeutics to Advance Gene Therapies

5/16/19 MILPITAS, Calif.–(BUSINESS WIRE) — ASC Therapeutics, A Division of Applied...

Read More

ASC Therapeutics Cures Hemophilia A Mice

4/25/19 MILPITAS, Calif.–(BUSINESS WIRE)– Applied StemCell, Inc. (ASC), a leading gene-editing company,...

Read More

Copyright © 2021 ASC Therapeutics

This website uses cookies to improve your experience. We'll assume you accept this policy as long as you are using this websiteAcceptLearn More